Palbociclib and trastuzumab for HER2-positive metastatic breast cancer (SOLTI-1303 PATRICIA): Final results from cohort A and B, prospective, open-label, multicenter phase II study

This article has no abstract
Epistemonikos ID: 2ee034e696af3df0fb6b50e613cca0ae7c85d8c6
First added on: Feb 14, 2025